Your browser doesn't support javascript.
loading
Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients.
Narayan, Ram N; McCreary, Morgan; Conger, Darrel; Wang, Cynthia; Greenberg, Benjamin M.
Afiliación
  • Narayan RN; Department of Neurology, Barrow Neurological Institute, Phoenix, AZ 85013, United States. Electronic address: ramnaren86@gmail.com.
  • McCreary M; University of Texas Southwestern, Department of Neurology and Neurotherapeutics, United States.
  • Conger D; University of Texas Southwestern, Department of Neurology and Neurotherapeutics, United States.
  • Wang C; University of Texas Southwestern, Department of Neurology and Neurotherapeutics, United States.
  • Greenberg BM; University of Texas Southwestern, Department of Neurology and Neurotherapeutics, United States.
Mult Scler Relat Disord ; 28: 86-90, 2019 Feb.
Article en En | MEDLINE | ID: mdl-30576847
BACKGROUND: Optic nerve involvement in anti-myelin oligodendrocyte glycoprotein antibody associated syndrome (MOG ab syndrome) tends to have unique features. Few studies have reported optical coherence tomography (OCT) measures like retinal nerve fiber layer thickness findings in the setting of pediatric MOG ab syndrome. OBJECTIVES: The aim of this study is to compare visual acuity between MOG ab positive and MOG ab negative pediatric cohorts and examine correlations with OCT findings. METHODS: We included outpatients less than 18 years of age who had optic neuritis (ON) of at least one eye and who completed visual testing and OCT in the study. ON was defined based on clinical or OCT findings. Antibody testing was obtained using cell-based assay. The primary analyses of interest investigated differences in low-contrast visual acuity stratified by the defined RNFL ranges and by antibody positivity. RESULTS: We analyzed 28 eyes from 14 anti-MOG ab patients (MOG-ON cohort), 18 eyes from 9 anti-AQP4 ab (AQP4-ON cohort) patients and 26 eyes from 13 patients who tested negative for both the antibodies (seronegative ON cohort). MOG-ON eyes with zero reported clinical events had lower RNFL thickness, than the minimum RNFL thickness of either the seronegative-ON or AQP4-ON eyes with zero clinical attacks in most retinal segments. Within the lowest range of the RNFL (RNFL <50 um) in most retinal segments, the MOG-ON cohort had a statistically significant greater visual acuity relative to the AQP4 cohort. CONCLUSIONS: Patients with anti-MOG antibody mediated CNS disorders can suffer from subclinical ON events with significant reductions in RNFL. Despite equally significant damage to the optic nerve, MOG-Ab positive patients have relatively preserved visual acuity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autoanticuerpos / Agudeza Visual / Neuritis Óptica / Tomografía de Coherencia Óptica / Ojo / Glicoproteína Mielina-Oligodendrócito Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Female / Humans / Male Idioma: En Revista: Mult Scler Relat Disord Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autoanticuerpos / Agudeza Visual / Neuritis Óptica / Tomografía de Coherencia Óptica / Ojo / Glicoproteína Mielina-Oligodendrócito Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Female / Humans / Male Idioma: En Revista: Mult Scler Relat Disord Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos